The LF MDA campaign functions both as a treatment delivery and data collection platform. For the LF treatment campaign considered in this study, community drug distributors (CDDs) responsible for administering the correct dose of albendazole and ivermectin also record the number of persons treated on a paper tally sheet. After, or in some cases during the MDA, this number is aggregated up through intermediate administrative levels (e.g., supervisory area, chiefdom, health area) to the health district, hereafter synonymous with implementation unit (IU). The total number of LF treatments in each treated district is reported to the national NTD program.
Population data were provided by the national NTD programs for each district conducting LF MDA. The data were provided each year, accounting for population growth, and were typically based on a national census. In certain years, a minority of the NTD programs included opted to use NTD-specific population estimates for (e.g., a pre-MDA community census conducted by the CDDs themselves). This was done in cases of population movement or where the national census was considered unreliable or too old to be accurate.
Treatment and population data were considered exactly as reported to implementing partners following the MDA and national validation. All treatment and population data were recorded for the district level along with the month and calendar year of the MDA start. All treatment, population, and calendar data were sourced directly from the USAID NTD database for countries currently participating in USAID’s Act to End NTDs | West program. District geographic boundary data (i.e. shapefiles) was also shared by the ten ministries of health to implementing partners during the course of implementation.
Population data were provided by the national NTD programs for each district conducting LF MDA. The data were provided each year, accounting for population growth, and were typically based on a national census. In certain years, a minority of the NTD programs included opted to use NTD-specific population estimates for (e.g., a pre-MDA community census conducted by the CDDs themselves). This was done in cases of population movement or where the national census was considered unreliable or too old to be accurate.
Treatment and population data were considered exactly as reported to implementing partners following the MDA and national validation. All treatment and population data were recorded for the district level along with the month and calendar year of the MDA start. All treatment, population, and calendar data were sourced directly from the USAID NTD database for countries currently participating in USAID’s Act to End NTDs | West program. District geographic boundary data (i.e. shapefiles) was also shared by the ten ministries of health to implementing partners during the course of implementation.
Free full text: Click here
